Related references
Note: Only part of the references are listed.MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma
Michaela B. Kirschner et al.
MOLECULAR ONCOLOGY (2015)
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
Nicola Amodio et al.
Oncotarget (2015)
Prognostic Implications for High Expression of MiR-25 in Lung Adenocarcinomas of Female Non-smokers
Fang-Xiu Xu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma
Zhong-xue Su et al.
DIAGNOSTIC PATHOLOGY (2014)
Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: Results from the EPIC-EURGAST study
Yolanda Espinosa-Parrilla et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component
Shinji Matsumoto et al.
MEDICAL ONCOLOGY (2014)
MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2
Shujun Feng et al.
TUMOR BIOLOGY (2014)
Role of epigenetics in human aging and longevity: genome-wide DNA methylation profile in centenarians and centenarians' offspring
Davide Gentilini et al.
AGE (2013)
Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a
Pei Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease
Marco Rossi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
An Extensive Network of TET2-Targeting MicroRNAs Regulates Malignant Hematopoiesis
Jijun Cheng et al.
CELL REPORTS (2013)
Age-dependent skewing of X chromosome inactivation appears delayed in centenarians' offspring. Is there a role for allelic imbalance in Healthy Aging and Longevity?
Davide Gentilini et al.
AGING CELL (2012)
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N. Amodio et al.
CELL DEATH & DISEASE (2012)
The Metastasis-Associated microRNA miR-516a-3p Is a Novel Therapeutic Target for Inhibiting Peritoneal Dissemination of Human Scirrhous Gastric Cancer
Yoshifumi Takei et al.
CANCER RESEARCH (2011)
Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening
S. F. M. Haeusler et al.
BRITISH JOURNAL OF CANCER (2010)
Distinctive MicroRNA profiles relating to patient survival in esophageal squamous cell carcinoma
Yong Guo et al.
CANCER RESEARCH (2008)
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
John A. Foekens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Bortezomib inhibits nuclear factor-κB-dependent survival and has potent in vivo activity in mesothelioma
Andrea Sartore-Bianchi et al.
CLINICAL CANCER RESEARCH (2007)
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes
Michele Carbone et al.
NATURE REVIEWS CANCER (2007)
TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis
Haining Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Medical progress - Advances in malignant mesothelioma
BWS Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Share Paper
